| Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions Á Hermida-Ameijeiras, E Méndez-Álvarez, S Sánchez-Iglesias, ... Neurochemistry international 45 (1), 103-116, 2004 | 173 | 2004 |
| Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons P Rey, A Lopez-Real, S Sanchez-Iglesias, A Munoz, R Soto-Otero, ... Neurobiology of Aging 28 (4), 555-567, 2007 | 118 | 2007 |
| Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6‐OHDA‐induced model of Parkinson’s disease S Sánchez‐Iglesias, E Méndez‐Álvarez, J Iglesias‐González, ... Journal of neurochemistry 109 (3), 879-888, 2009 | 99 | 2009 |
| A new seipin-associated neurodegenerative syndrome E Guillén-Navarro, S Sánchez-Iglesias, R Domingo-Jiménez, B Victoria, ... Journal of medical genetics 50 (6), 401-409, 2013 | 79 | 2013 |
| Analysis of brain regional distribution of aluminium in rats via oral and intraperitoneal administration S Sánchez-Iglesias, R Soto-Otero, J Iglesias-Gonzalez, ... Journal of Trace Elements in Medicine and Biology 21, 31-34, 2007 | 73 | 2007 |
| Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson’s disease S Sánchez-Iglesias, P Rey, E Mendez-Alvarez, JL Labandeira-Garcia, ... Neurochemical Research 32, 99-105, 2007 | 67 | 2007 |
| Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase J Iglesias-González, S Sánchez-Iglesias, E Méndez-Álvarez, S Rose, ... Neurochemical research 37, 2150-2160, 2012 | 54 | 2012 |
| Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome C Guillín-Amarelle, S Sánchez-Iglesias, A Castro-Pais, ... Endocrine 54, 411-421, 2016 | 50 | 2016 |
| Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience D Araujo-Vilar, S Sánchez-Iglesias, C Guillín-Amarelle, A Castro, M Lage, ... Endocrine 49, 139-147, 2015 | 48 | 2015 |
| A simple method for isolating rat brain mitochondria with high metabolic activity: effects of EDTA and EGTA J Iglesias-González, S Sánchez-Iglesias, A Beiras-Iglesias, R Soto-Otero, ... Journal of Neuroscience Methods 213 (1), 39-42, 2013 | 34 | 2013 |
| Inhibition of 6-hydroxydopamine-induced oxidative damage by 4, 5-dihydro-3H-2-benzazepine N-oxides R Soto-Otero, E Méndez-Álvarez, S Sánchez-Iglesias, FI Zubkov, ... biochemical pharmacology 75 (7), 1526-1537, 2008 | 30 | 2008 |
| Lipodystrophic laminopathies: Diagnostic clues C Guillín-Amarelle, A Fernández-Pombo, S Sánchez-Iglesias, ... Nucleus 9 (1), 277-288, 2018 | 27 | 2018 |
| Effects of aluminium on rat brain mitochondria bioenergetics: an in vitro and in vivo study J Iglesias-González, S Sánchez-Iglesias, A Beiras-Iglesias, ... Molecular neurobiology 54, 563-570, 2017 | 27 | 2017 |
| Study on the ability of 1, 2, 3, 4‐tetrahydropapaveroline to cause oxidative stress: Mechanisms and potential implications in relation to parkinson's disease R Soto‐Otero, C Sanmartín‐Suárez, S Sánchez‐Iglesias, ... Journal of Biochemical and Molecular Toxicology 20 (5), 209-220, 2006 | 22 | 2006 |
| Larger aggregates of mutant seipin in Celia's Encephalopathy, a new protein misfolding neurodegenerative disease A Ruiz-Riquelme, S Sánchez-Iglesias, A Rábano, E Guillén-Navarro, ... Neurobiology of disease 83, 44-53, 2015 | 20 | 2015 |
| 2‐Benzazepine nitrones protect dopaminergic neurons against 6‐hydroxydopamine‐induced oxidative toxicity R Soto‐Otero, E Méndez‐Álvarez, S Sánchez‐Iglesias, ... Archiv der Pharmazie 345 (8), 598-609, 2012 | 18 | 2012 |
| LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A Y Tu, S Sánchez-Iglesias, D Araújo-Vilar, LG Fong, SG Young Nucleus 7 (5), 512-521, 2016 | 17 | 2016 |
| Does seipin play a role in oxidative stress protection and peroxisome biogenesis? New insights from human brain autopsies S Sánchez-Iglesias, A Fernandez-Liste, C Guillín-Amarelle, A Rábano, ... Neuroscience 396, 119-137, 2019 | 14 | 2019 |
| Association of metreleptin treatment and dietary intervention with neurological outcomes in Celia’s encephalopathy D Araújo-Vilar, R Domingo-Jiménez, Á Ruibal, P Aguiar, S Ibáñez-Micó, ... European Journal of Human Genetics 26 (3), 396-406, 2018 | 13 | 2018 |
| A de novo heterozygous missense BSCL2 variant in 2 siblings with intractable developmental and epileptic encephalopathy A Fernández-Marmiesse, S Sánchez-Iglesias, A Darling, MM O'Callaghan, ... Seizure 71, 161-165, 2019 | 11 | 2019 |
David Araujo-VilarProfessor of Medicine, Universidade de Santiago de CompostelaVerified email at usc.es
